Oct 13, 20223 minCarmine Therapeutics Announces First Close of Series A to Develop Non-viral Gene TherapyCambridge, MA, October 13, 2022 -- Carmine Therapeutics (“Carmine”), an EVX founded biotech company and emerging leader in non-viral gene...
May 5, 20212 minCarmine Therapeutics appoints Don Haut as CEOCAMBRIDGE, Mass., May 5, 2021 /PRNewswire/ -- Carmine Therapeutics, Inc., an emerging leader in gene therapy, today announced that Don...
Sep 28, 20202 minCarmine Therapeutics named as one of FierceBiotech’s “Fierce 15” Biotech Companies of 2020Cambridge, MA / 28 Sep 2020 – Carmine Therapeutics announced today that it has been named by FierceBiotech as one of 2020’s Fierce 15...
Aug 7, 20201 minProf Mark Kay MD, PhD Joins Carmine's Scientific Advisory BoardA warm welcome to Professor Mark Kay MD, PhD to our Scientific Advisory Board! His renowned expertise in gene therapy will provide...
Jun 30, 20202 minCarmine Therapeutics & Takeda Collaborate to Develop Novel Non-viral Gene TherapiesCarmine Therapeutics and Takeda Collaborate to Discover and Develop Rare Disease Gene Therapies Using Novel RBCEVs Platform.
Dec 10, 20193 minCarmine Therapeutics Wins the Bristol-Myers Squibb’s 2019 Golden TicketCarmine Therapeutics is proud to announce that it has won the Bristol-Myers Squibb’s 2019 Golden Ticket for LabCentral.